[SLRX] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
02-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -2.42%
YoY- 0.54%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 1,269 1,133 105 179 243 0 0 -
PBT -1,852 -2,084 -2,230 -8,223 -8,268 -9,592 -6,018 -17.81%
Tax 47 -286 0 0 0 0 0 -
NP -1,852 -2,084 -2,230 -8,223 -8,268 -9,592 -6,018 -17.81%
Tax Rate - - - - - - - -
Total Cost 3,121 3,217 2,335 8,402 8,511 9,592 6,018 -10.35%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -145.95 -183.95 -2,124.68 -4,604.73 -3,408.99 0.00 0.00 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -1.52 -5.46 -77.16 -287.22 -306.27 -378.42 -369.47 -59.93%
EPS Diluted -1.52 -5.46 -77.16 -287.22 -306.27 -378.42 -369.47 -59.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.